These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 20493715)

  • 1. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM; Jammaz IA
    Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
    Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and physicochemical characterization of carbon backbone modified [Gd(TTDA)(H2O)]2- derivatives.
    Chang YH; Chen CY; Singh G; Chen HY; Liu GC; Goan YG; Aime S; Wang YM
    Inorg Chem; 2011 Feb; 50(4):1275-87. PubMed ID: 21247114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new high affinity technetium analogue of bombesin containing DTPA as a pharmacokinetic modifier.
    Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Pili R; Pomper M; Carducci M; Wagner HN
    Bioconjug Chem; 2004; 15(6):1416-23. PubMed ID: 15546210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gd(Try-TTDA)(H2O)]2-: a new MRI contrast agent for copper ion sensing.
    Kasala D; Lin TS; Chen CY; Liu GC; Kao CL; Cheng TL; Wang YM
    Dalton Trans; 2011 May; 40(18):5018-25. PubMed ID: 21451883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterization of the novel monoamide derivatives of Gd-TTDA.
    Wang YM; Li CR; Huang YC; Ou MH; Liu GC
    Inorg Chem; 2005 Jan; 44(2):382-92. PubMed ID: 15651885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor.
    Parry JJ; Andrews R; Rogers BE
    Breast Cancer Res Treat; 2007 Jan; 101(2):175-83. PubMed ID: 16838112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
    Fragogeorgi EA; Zikos C; Gourni E; Bouziotis P; Paravatou-Petsotas M; Loudos G; Mitsokapas N; Xanthopoulos S; Mavri-Vavayanni M; Livaniou E; Varvarigou AD; Archimandritis SC
    Bioconjug Chem; 2009 May; 20(5):856-67. PubMed ID: 19344122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.
    Ananias HJ; Yu Z; Dierckx RA; van der Wiele C; Helfrich W; Wang F; Yan Y; Chen X; de Jong IJ; Elsinga PH
    Mol Pharm; 2011 Aug; 8(4):1165-73. PubMed ID: 21699202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.
    Schroeder RP; van Weerden WM; Bangma C; Krenning EP; de Jong M
    Methods; 2009 Jun; 48(2):200-4. PubMed ID: 19398012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.
    Nam T; Park S; Lee SY; Park K; Choi K; Song IC; Han MH; Leary JJ; Yuk SA; Kwon IC; Kim K; Jeong SY
    Bioconjug Chem; 2010 Apr; 21(4):578-82. PubMed ID: 20201550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection.
    Chen YJ; Wu SC; Chen CY; Tzou SC; Cheng TL; Huang YF; Yuan SS; Wang YM
    Biomaterials; 2014 Jan; 35(1):304-15. PubMed ID: 24120038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
    J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.